News from emmaus life sciences, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 31, 2023, 14:11 ET Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease treatment, announced today that it has received a Medicine Registration...

May 15, 2023, 09:30 ET Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business Update

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...

Apr 03, 2023, 11:00 ET Emmaus Life Sciences Provides Interim Shipment Data

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle ell disease treatment, announced today preliminary results for the 3 months ended March...

Mar 31, 2023, 16:15 ET Emmaus Life Sciences Reports 2022 Financial Results and Provides Business Update

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...

Dec 20, 2022, 10:00 ET Dr. Niihara Meets with Local Indian Governor

Emmaus Life Sciences, Inc. (OTCQX: EMMA), announced today that Dr. Yutaka Niihara, Chairman and Chief Executive Officer of the company, was hosted in ...

Dec 19, 2022, 10:00 ET Dr. Niihara Feted by Indian Government in Recognition of the Development of Endari®

Emmaus Life Sciences, Inc. (OTCQX: EMMA), announced today that Dr. Yutaka Niihara, Chairman and Chief Executive Officer of the company, was feted at...

Dec 07, 2022, 14:25 ET Endari® Receives Kuwaiti Marketing Authorization

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease treatment, announced today that it has received Registration Approval from...

Nov 17, 2022, 09:30 ET Emmaus Life Sciences Receives Endari® Marketing Authorization from the Qatar Ministry of Public Health

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today that it has been issued a Registration...

Nov 14, 2022, 19:42 ET Emmaus Life Sciences Reports Q3 2022 Financial Results and Provides Business Update

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...

Sep 28, 2022, 06:30 ET Emmaus Life Sciences Announces Collaboration with Kier (Junior) Spates to Share Personal Experience with Sickle Cell Disease and Endari®

Emmaus Life Sciences, Inc. (OTCQX: EMMA) a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...

Aug 15, 2022, 16:30 ET Emmaus Life Sciences Reports Q2 2022 Financial Results and Provides Business Update

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...

Jul 12, 2022, 10:00 ET Emmaus Life Sciences Announces Engagement of Strategic Business Relations and Professional Services Advisor

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...

May 13, 2022, 08:23 ET Emmaus Life Sciences Reports Q1 2022 Financial Results and Provides Business Update

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...

Apr 26, 2022, 08:23 ET Emmaus Life Sciences to Present at Investor Conferences in May

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...

Apr 11, 2022, 08:23 ET Emmaus Life Sciences Announces Launch of Full-Service Telehealth Solution

Emmaus Life Sciences, Inc. (OTQXC: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...

Apr 07, 2022, 08:23 ET Emmaus Life Sciences Presented Positive Real-World Data on the Efficacy of Endari® in Preventing Acute Complications from Sickle Cell Disease at the 62nd Annual Scientific Meeting of the British Society for Haematology

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...

Mar 31, 2022, 17:24 ET Emmaus Life Sciences Reports 2021 Financial Results and Provides Business Update

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...

Mar 29, 2022, 08:23 ET Emmaus Life Sciences Announces Endari® To Be Added to the Florida Medicaid Preferred Drug List

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in the treatment of sickle cell disease, announced today that the Florida Medicaid Pharmaceutical...

Mar 23, 2022, 08:23 ET Emmaus Life Sciences Receives U.A.E. Marketing Authorization for Endari®

Emmaus Life Sciences, Inc. (OTCQX: EMMA) a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...

Mar 04, 2022, 08:23 ET Emmaus Life Sciences' Real World Data on Endari® Accepted for E-Poster at the 62nd Annual Scientific Meeting of the British Society for Haematology

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...

Jan 04, 2022, 08:23 ET Emmaus Life Sciences to Present at the H.C. Wainwright BioConnect Conference

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...

Dec 14, 2021, 08:23 ET Emmaus Life Sciences Presents Positive Transfusion Data from a Post-Hoc Analysis of its Phase 3 Clinical Study of Endari® in Patients With Sickle Cell Disease at the 63rd American Society of Hematology (ASH) Annual Meeting

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...

Dec 06, 2021, 08:23 ET Emmaus Life Sciences' Data on Endari® Accepted for Poster Presentation at the 63rd American Society of Hematology Annual Meeting & Exhibition

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...

Nov 12, 2021, 08:23 ET Emmaus Life Sciences Reports Third Quarter Financial Results and Business Highlights

Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...

Nov 11, 2021, 08:23 ET Emmaus Life Sciences Announces Partnership with UpScript to Provide Telehealth Solutions to Sickle Cell Disease Patients

Emmaus Life Sciences, Inc. (OTCQX: EMMA) a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today...